78345-58-1

Basic information

• Product Name: 4-CYCLOHEXYLAMINO-BUTAN-1-OL
• Synonyms: TIMTEC-BB SBB000173;4-CYCLOHEXYLAMINO-BUTAN-1-OL;AKOS BBB/410
• CAS NO: 78345-58-1
• Molecular Formula: C₁₀H₂₁NO
• Molecular Weight: 171.28
• Mol File: 78345-58-1.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 280.9°C at 760 mmHg
• Flash Point: 93.9°C
• Appearance: /
• Vapor Pressure: 0.000438mmHg at 25°C
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: 4-CYCLOHEXYLAMINO-BUTAN-1-OL(CAS DataBase Reference)
• NIST Chemistry Reference: 4-CYCLOHEXYLAMINO-BUTAN-1-OL(78345-58-1)
• EPA Substance Registry System: 4-CYCLOHEXYLAMINO-BUTAN-1-OL(78345-58-1)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 78345-58-1(Hazardous Substances Data)

Usage

General Description

4-Cyclohexylamino-butan-1-ol is a chemical compound with the molecular formula C10H21NO. It is a secondary amine containing a cyclohexyl group and a butanol group. 4-CYCLOHEXYLAMINO-BUTAN-1-OL has a variety of potential applications, including its use as a building block in the synthesis of pharmaceuticals and organic compounds. It is also used in the production of surfactants, emulsifiers, and other specialty chemicals. 4-Cyclohexylamino-butan-1-ol is considered to be a versatile and valuable chemical for use in a range of industrial and research applications.

InChI:InChI=1/C10H21NO/c12-9-5-4-8-11-10-6-2-1-3-7-10/h10-12H,1-9H2/p+1

Upstream product

• 13325-10-5 4-Aminobutanol 
• 108-94-1 cyclohexanone 
• 71-43-2 benzene 
• 110-63-4 Butane-1,4-diol 
• 108-91-8 cyclohexylamine 
• 20388-04-9 γ-hydroxybutyric acid N-cyclohexylamide 
• 58539-81-4 cyclohexyl-dihydrofuran-2-ylidene-amine 
• 21451-32-1 4-(cyclohexylamine)-4-oxobutanoic acid 

Downstream Products

• 78345-72-9 N-Cyclohexyl-N-(4-hydroxy-butyl)-4-(2-oxo-1,2-dihydro-quinolin-6-yloxy)-butyramide 
• 105695-33-8 N-Cyclohexyl-N-(4-hydroxy-butyl)-4-(2-oxo-1,2,3,5-tetrahydro-imidazo[2,1-b]quinazolin-7-yloxy)-butyramide 

Relevant articles and documents

Benzenesulfonamide Derivatives as Calcium/Calmodulin-Dependent Protein Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus Infections

Emerging and resurging mosquito-borne flaviviruses are an important public health challenge. The increased prevalence of dengue virus (DENV) infection has had a significant socioeconomic impact on epidemic countries. The recent outbreak of Zika virus (ZIK

HETEROCYCLIC COMPOUND DERIVATIVES AND MEDICINES

The present invention provides a compound which is useful as a PGI2 receptor agonist, and a pharmaceutical composition. The present invention is directed to a pharmaceutical composition comprising a compound represented by the following formula [1]: (R1 and R2 are the same or different and each represents optionally substituted aryl, Y represents N or CH, Z represents N or CH, A represents NH, NR5, O, S, or ethylene, R5 represents alkyl, D represents alkylene or alkenylene, E represents phenylene or single bond, G represents O, S, or CH2, R3 and R4 are the same or different and each represents hydrogen or alkyl, Q represents carboxy, alkoxycarbonyl, tetrazolyl, carbamoyl, or N-(alkylsulfonyl)carbamoyl), or a pharmaceutically acceptable salt thereof as an active ingredient.